Perrigo to acquire Omega in €3.6 billion deal

6 November 2014 - Deborah Wilkes

Archived

Perrigo has agreed to acquire OTC specialist Omega Pharma in a cash and equity deal worth €3.6 billion (US$4.5 billion), including the assumption of €1.1 billion in debt. The deal will create "a top five global OTC company", says Perrigo, and a combined company with annual sales of around US$5.7 billion.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: